NxStage Medical Inc. | Ownership
Companies that own NxStage Medical Inc.
The Vanguard Group, Inc.
5,728,885
8.74%
166,336
0.01%
06/30/2018
BlackRock Fund Advisors
4,599,872
7.01%
357,558
0.01%
06/30/2018
TIG Advisors LLC
3,488,299
5.32%
1,787,017
5.22%
06/30/2018
Alpine Associates Management, Inc.
3,326,982
5.07%
30,300
3.32%
06/30/2018
Magnetar Financial LLC
3,069,529
4.68%
12,969
1.48%
06/30/2018
CNH Partners LLC
2,884,391
4.4%
-124,862
1.43%
06/30/2018
Flossbach von Storch AG
2,732,413
4.17%
-260,786
0.38%
06/30/2018
SSgA Funds Management, Inc.
1,529,149
2.33%
99,885
0%
06/30/2018
Water Island Capital LLC
1,334,420
2.04%
149,713
2.22%
06/30/2018
Grantham, Mayo, Van Otterloo & Co. LLC
1,016,840
1.55%
-406,365
0.08%
06/30/2018
| Address |
350 Merrimack Street
Lawrence Massachusetts 01843
United States
|
|
Employees
|
- |
| Website |
http://www.nxstage.com |
| Updated |
09/14/2018 |
| NxStage Medical, Inc. is a medical technology company, which develops, manufactures, and markets products for the treatment of ESRD and acute kidney failure. It operates through the following business segments: System One, In-Center, and Services. The System One segment engages in the sale and rental of the System One and PureFlow SL equipment and the sale of disposable products in the home and critical care markets. |
